[HTML][HTML] Early diagnosis of pancreatic ductal adenocarcinoma by combining relative expression orderings with machine-learning method

ZM Zhang, JS Wang, H Zulfiqar, H Lv… - Frontiers in Cell and …, 2020 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal cancer deeply
affecting human health. Diagnosing early-stage PDAC is the key point to PDAC patients' …

[HTML][HTML] Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma

H Klett, H Fuellgraf, E Levit-Zerdoun, S Hussung… - Frontiers in …, 2018 - frontiersin.org
Late diagnosis and systemic dissemination essentially contribute to the invariably poor
prognosis of pancreatic ductal adenocarcinoma (PDAC). Therefore, the development of …

Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma

S Akrami, A Tahmasebi, A Moghadam… - Computers in Biology …, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is one of the most death-dealing tumors, with a
tremendously poor prognosis. Here, we, through interrogation of mRNA and protein data …

[HTML][HTML] Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets

L Liu, S Wang, C Cen, S Peng… - Molecular …, 2019 - spandidos-publications.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignant tumor with
rapid progression and poor prognosis. In the present study, 11 high‑quality microarray …

[HTML][HTML] Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier

MK Bhasin, K Ndebele, O Bucur, EU Yee, HH Otu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma
classifier - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

[HTML][HTML] Biomarker panel for the diagnosis of pancreatic ductal adenocarcinoma

H Kim, KN Kang, YS Shin, Y Byun, Y Han, W Kwon… - Cancers, 2020 - mdpi.com
A single tumor marker has a low diagnostic value in pancreatic cancer. Combinations of
multiple biomarkers and unique analysis algorithms can be applied to overcome these …

[HTML][HTML] Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes

L Zhao, H Zhao, H Yan - BMC cancer, 2018 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of
cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC …

Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development

M Giulietti, G Occhipinti, G Principato, F Piva - Cellular Oncology, 2016 - Springer
Purpose Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Up
till now, the patient's prognosis remains poor which, among others, is due to the paucity of …

[HTML][HTML] Prognostic fifteen-gene signature for early stage pancreatic ductal adenocarcinoma

DT Chen, AH Davis-Yadley, PY Huang, K Husain… - PloS one, 2015 - journals.plos.org
The outcomes of patients treated with surgery for early stage pancreatic ductal
adenocarcinoma (PDAC) are variable with median survival ranging from 6 months to more …

[HTML][HTML] Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions

W Lin, P Noel, EH Borazanci, J Lee, A Amini, IW Han… - Genome medicine, 2020 - Springer
Background Solid tumors such as pancreatic ductal adenocarcinoma (PDAC) comprise not
just tumor cells but also a microenvironment with which the tumor cells constantly interact …